Novo Nordisk A/S vs Super Micro Computer Inc — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Super Micro Computer Inc trades at $30.08 (market cap $15.41B). The key difference: Novo Nordisk A/S is far larger — about 14.3× Super Micro Computer Inc's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Super Micro Computer Inc pays none. Which is the better fit depends on your goals.
| NVO | SMCI | |
|---|---|---|
Market Cap | $220.53B | $15.41B |
Sector | Health | Technology |
52-Week High | $71.70 | $60.71 |
52-Week Low | $35.29 | $20.53 |
Enterprise Value | $239.49B | $22.93B |
Dividend Yield | 3.63% | — |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.
Read more on SMCI →